In 2003, the WHO classification of breast tumors established that NEBC should exhibit morphological features similar to those of NE tumors of the gastrointestinal tract and lungs together with the immunohistochemical expression of NE markers (i.e., chromogranin and synaptophysin) in more than 50% of the tumor cell population (7). This evidence concerns the gene SYP and neoplasm.